A media briefing with experts from the Infectious Diseases Society of America to discuss coronavirus and COVID-19 developments and answer questions.
Topical Agenda for April 7 Briefing:
--The state of coronavirus diagnostic testing in the United States
--There are now more than 20 test options approved by the FDA, but availability is still limited. Why?
--What accounts for differences in test performance, accuracy, and result time?
--What is the potential application of antibody-based tests?
--What's next in COVID-19 diagnostics?
--Questions from media
FEATURING:
Angela M. Caliendo, MD, PhD, FIDSA — Providence, Rhode Island
Secretary, Board of Directors—Infectious Diseases Society of America
Professor and Executive Vice Chair, Department of Medicine, Alpert Medical School, Brown University
Kimberly E. Hanson, MD, MHS — Salt Lake City, Utah
Member, Board of Directors—Infectious Diseases Society of America
Associate Professor, Internal Medicine, University of Utah School of Medicine
Adjunct Associate Professor, Pathology, University of Utah School of Medicine
Chris Busky, CAE (Moderator)
Chief Executive Officer, Infectious Diseases Society of America
